Properties
Description
(R)-BPO-27 blocks the activity of the cystic fibrosis transmembrane conductance regulator protein, which plays a crucial role in the movement of chloride ions across cell membranes.
Molecular Formula
C26H18BrN3O6
Identity
Confirmed by NMR/HPLC/MS.
Applications
(R)-BPO-27, a CFTR inhibitor, is used to explore its potential in treating cystic fibrosis by altering chloride transport in epithelial tissues.